SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.

Processa Pharmaceuticals Inc

PCSA is experiencing high volatility, with numerous trading halts, following preliminary Phase 2 data regarding its breast cancer treatment. Community discussions revolve around profit-taking strategies, potential short squeezes, and the possibility of future news or partnerships. The stock's low float and recent reverse split are also contributing to the heightened speculation.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla ($TSLA) is trending as it nears all-time highs, with community discussions focused on whether it can break through the $500 mark. Optimism is fueled by robotaxi progress and AI integration, though concerns persist about valuation and potential sales restrictions. The debate centers around whether the stock is driven by genuine innovation or speculative hype.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending downwards, with community members expressing frustration over the stock's continued decline despite positive news and strong revenue projections, with some citing concerns about management and potential links to Oracle's struggles; this has led to speculation about possible short squeezes, strategic realignments or a re-evaluation of the stock's fair value.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending due to concerns around its AI infrastructure spending and a pulled funding deal for a new data center, leading to fears of overleverage and negative cash flow; however, some investors see this as an overreaction and a buying opportunity, anticipating a rebound. Community discussions revolve around the stock's recent sharp decline, potential support levels, and the broader implications for the AI sector. Some traders speculate about market manipulation and the possibility of a short squeeze.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave (CRWV) is experiencing significant volatility, with community discussions focusing on a recent sharp decline despite a lack of negative company-specific news, and institutional buying. Investors are debating whether this dip presents a buying opportunity or signals deeper issues related to debt, insider selling, and broader AI market sentiment. Concerns about data center delays and comparisons to other AI-related stocks like NVDA and ORCL are also prevalent.

$SMOL is the first memecoin with a verified OnlyFans launched on Solana via pump.fun. It follows Smol, a rescued Alabama dachshund who survived hoarding, shelter hunger, and a 5-day post-spay escape before finding her forever home. Now pampered with treats and spa days, she shares wholesome content—no adult themes, just derpy faces, snack videos, and rescue love. $SMOL aims to normalize kindness and support animal welfare through the creator economy.

Smol Fans

SMOL CRYPTO is trending due to its unique narrative as a rescue dog with an OnlyFans account, generating community excitement around its charitable angle and potential to disrupt the meme coin landscape. Community members are actively discussing its potential to flip other memecoins and even outperform mainstream platforms, fueled by celebrity endorsements and a strong, dedicated community.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

TLRY is trending amid anticipation surrounding potential marijuana rescheduling, fueled by reports of an upcoming executive order. Community discussions range from planned entries and exits to speculation on the timing and impact of the news, with some cautioning against hype while others predict a significant rally. The broader context involves the cannabis sector's potential transformation and TLRY's position within it, though opinions vary on whether it or other companies will benefit most.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

The crypto, $401JK, is trending as community members celebrate the recent launch of staking, with many drawing parallels to traditional retirement funds and expressing excitement about potential yields. Community members highlight the token's narrative of providing an alternative to traditional 401ks. Some members are discussing their plans to stake their tokens for the long term, and touting staking's benefits.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom (AVGO) is trending downwards as investors react to recent performance despite positive earnings, with community members expressing frustration over the stock's inability to sustain gains. Some are attributing the selloff to Blue Owl investment news and broad market factors affecting the AI sector, while others see potential for a rebound and are buying the dip. Concerns about valuation, competition, and overall market manipulation are also fueling the conversation.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending as investors discuss recent price drops and potential bottom levels, with some expressing frustration while others see it as a buying opportunity. Community members are also closely watching for news regarding a potential partnership with Amazon, which is seen as a major catalyst. Despite recent market volatility, there's continued long-term confidence in the battery technology sector and AMPX's potential, especially with new contract manufacturers in Korea.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Galectin Therapeutics (NASDAQ:GALT) Director Sells $105,273.30 in Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) Director Harold Shlevin sold 16,790 shares of the company's stock in a transaction on Tuesday, December 9th. The shares were sold at an...

Galectin Therapeutics (NASDAQ:GALT) Director Sells $950,820.00 in Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) Director Harold Shlevin sold 159,000 shares of the company's stock in a transaction on Monday, December 8th. The shares were sold at an...

Fund L.P. 10X Sells 120,000 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) major shareholder Fund L.P. 10X sold 120,000 shares of Galectin Therapeutics stock in a transaction on Wednesday, December 3rd. The shares...

Galectin Therapeutics (NASDAQ:GALT) Major Shareholder Fund L.P. 10X Sells 30,000 Shares

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) major shareholder Fund L.P. 10X sold 30,000 shares of the business's stock in a transaction that occurred on Tuesday, December 2nd. The...

Galectin Therapeutics (NASDAQ:GALT) Major Shareholder Sells $164,100.00 in Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) major shareholder Fund L.P. 10X sold 30,000 shares of the firm's stock in a transaction on Tuesday, December 2nd. The shares were sold at an...

Wealthspire Advisors LLC Buys 81,144 Shares of Galectin Therapeutics Inc. $GALT

Wealthspire Advisors LLC lifted its stake in shares of Galectin Therapeutics Inc. (NASDAQ:GALT - Free Report) by 20.4% during the second quarter, according to its most recent filing with the...

Galectin Therapeutics (NASDAQ:GALT) Insider Sells 121,117 Shares

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) insider Khurram Jamil sold 121,117 shares of the firm's stock in a transaction dated Thursday, November 13th. The shares were sold at an...

Galectin Therapeutics (NASDAQ:GALT) Releases Earnings Results, Misses Estimates By $0.02 EPS

Galectin Therapeutics (NASDAQ:GALT - Get Free Report) announced its earnings results on Friday. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of...

Khurram Jamil Sells 121,117 Shares of Galectin Therapeutics (NASDAQ:GALT) Stock

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) insider Khurram Jamil sold 121,117 shares of the business's stock in a transaction on Thursday, November 13th. The shares were sold at an...

Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened

Galectin Therapeutics (NASDAQ:GALT) Share Price Crosses Above Two Hundred Day Moving Average - What's Next...

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Stocktwits Polls

Traders are using "brownies" as a coded reference, hinting at anticipated positive FDA guidance or approval for its lead drug candidate, Belapectin, sparking optimism for significant price action.

Discussions center around H.C. Wainwright's recent analyst upgrade, raising the price target to $11 from $6, fueling renewed optimism and driving the stock's recent rally.

The community is buzzing about the $7 strike price warrants, discussing their exercise, value, and potential impact on current and future share price.

Anticipation is building for a potential short squeeze, with traders closely watching short interest and volume, hoping an upcoming catalyst will ignite a rapid price surge.

Enthusiastic traders celebrate the stock reaching new 52-week highs, viewing it as a sign of strong bullish momentum and a precursor to further gains.

GALT
Galectin Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest GALT News

GALTGalectin Therapeutics Inc